Reduction by gabapentin of K +-evoked release of [ 3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat

British Journal of Pharmacology

Volumn 141, Issue 4, 2004, Pages 574-579

  Maneuf, Y P ^a   Blake, R ^b   Andrews, N A ^c   McKnight, A T ^d  

^a Cambridge Biotechnology Ltd   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Oxford Natural Products   (United Kingdom)

Author keywords

Diabetic neuropathy; Gabapentin; Glutamatergic transmission; Spinal trigeminal nucleus; Streptozotocin

Indexed keywords

GABAPENTIN; GLUCOSE; GLUTAMIC ACID; POTASSIUM ION; STREPTOZOCIN; SUBSTANCE P;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERALGESIA; INHIBITION KINETICS; MALE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TACTILE STIMULATION; TISSUE SLICE; TRIGEMINAL NUCLEUS;

ACETIC ACIDS; AMINES; ANIMALS; BLOOD GLUCOSE; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; POTASSIUM; RATS; TRIGEMINAL NUCLEI;

EID: 1842453947     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705579     Document Type: Article

References (32)

1. BACKONJA, M., BEYDOUN, A., EDWARDS, K.R., SCHWARTZ, S.L., FONSECA, V., HES, M., LAMOREAUX, L. & GAROFALO, E. (1998). Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA, 280, 1831-1836.
2. CALCUTT, N.A. & CHAPLAN, S.R. (1997). Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol., 122, 1478-1482.
3. CHAPLAN, S.R., BACH, F.W., POGREL, J.W., CHUNG, J.M. & YAKSH, T.L. (1994). Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods, 53, 55-63.
4. COUDORÉ-CIVIALE, M.A., COURTEIX, C., BOUCHER, M., FIALIP, J. & ESCHALIER, A. (2000). Evidence for an involvement of tachykinins in allodynia in streptozotocin-induced diabetic rats. Eur. J. Pharmacol., 401, 47-53.
5. DICKENSON, A.H., CHAPMAN, V. & GREEN, G.M. (1997). The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol., 28, 633-638.
6. 3H]-norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J. Pharmacol. Exp. Ther., 295, 1086-1093.
7. +-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci. Lett., 280, 107-110.
8. FIELD, M.J., MCCLEARY, S., HUGHES, J. & SINGH, L. (1999). Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain, 80, 391-398.
9. FOX, A., EASTWOOD, C., GENTRY, C., MANNING, D. & URBAN, L. (1999). Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain, 81, 307-316.
10. 2 subunit of a calcium channel. J. Biol. Chem., 271, 5768-5776.
11. GILLIATT, R.W. (1965). Clinical aspects of diabetes. In: Biochemical Aspects of Neurological Disorders. ed. Cummings, J.N. & Kremer, M. pp. 117-142. Oxford: Blackwell.
12. HU, H.Z., LI, Z.W. & SI, J.Q. (1997). Evidence for the existence of substance P autoreceptor in the membrane of rat dorsal root ganglion neurons. Neuroscience, 77, 535-541.
13. JENSEN, A.A., MOSBACHER, J., ELG, S., LINGENHOEHL, K., LOHMANN, T., JOHANSEN, T.N., ABRAHAMSEN, B., MATTSSON, J.P., LEHMANN, A., BETTLER, B. & BRAUNER-OSBORNE, H. (2002). The anticonvulsant gabapentin (Neurontin) does not act through gamma aminobutyric acid-B receptors. Mol. Pharmacol., 61, 1377-1384.
14. LIU, H., MANTYH, P.W. & BASBAUM, A.I. (1997). NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature, 386, 721-724.
15. LYNCH III, J.J., JARVIS, M.F. & KOWALUK, E.A. (1999). An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain. Eur J Pharmacol, 364, 141-146.
16. MADL, J.E. & ROYER, S.M. (1999). Glutamate in synaptic terminals is reduced by lack of glucose but not hypoxia in rat hippocampal slices. Neuroscience, 94, 417-430.
17. 3H]glutamate from rat caudal trigeminal nucleus slices. Pain, 93, 191-196.
18. MILLAN, M.J. (1999). The induction of pain: an integrative review. Prog. Neurobiol., 57, 1-164.
19. MUSCAS, G.C., CHIROLI, S., LUCERI, F., MASTIO, M.D., BALESTRIERI, F. & ARNETOLI, G. (2000). Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels. Seizure, 9, 47-50.
20. NABARRO, J.D. (1991). Diabetes in the United Kingdom: a personal series. Diabet. Med., 8, 59-68.
21. NG, G.Y.K., BERTRAND, S., SULLIVAN, R., ETHIER, N., WANG, J., YERGEY, J., BELLEY, M., TRIMBLE, L., BATEMAN, K., ALDER, L., SMITH, A., MCKERNAN, R., METTERS, K., O'NEILL, G.P., LACAILLE, J.-C. & HERBERT, T.E. (2001). aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol., 59, 144-152.
22. PATEL, M.K., GONZALEZ, M., BRAMWELL, S., PINNOCK, R.D. & LEE, K. (2000). Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br. J. Pharmacol., 130, 1731-1734.
23. PAXINOS, G & WATSON, C (1986). The Rat Brain in Stereotaxic Coordinates. 2nd edn.. Sydney: Academic Press.
24. SAMSAM, M., COVENAS, R., AHANGARI, R., YAJEYA, J., NARVAEZ, J.A. & TRAMU, G. (2000). Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion. Pain, 84, 389-395.
25. SHIMOYAMA, M., SHIMOYAMA, N. & HORI, Y. (2000). Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain, 85, 405-414.
26. TANCREDE, G., ROUSSEAU-MIGNERON, S. & NADEAU, A. (1983). Long-term changes in the diabetic stae induced by different doses of streptozotocin in rats. Br. J. Exp. Pathol., 64, 117-123.
27. THOMAS, P.K. & TOMLINSON, D.R. (1993). Diabetic and hypoglycaemic neuropathy. In: Peripheral Neuropathy. 3rd edn. ed. Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A. & Podusl, J.F. pp. 1219-1250. Philadelphia: Saunders WB.
28. TIMMERMAN, W., BOUMA, M., DE VRIES, J.B., DAVIS, M. & WESTERINK, B.H. (2000). A microdialysis study on the mechanism of action of gabapentin. Eur. J. Pharmacol., 398, 53-57.
29. TRACEY, D.J. (1985). Somatosensory system. In: The Rat Nervous System. Vol. 2, Hindbrain and Spinal cord. ed. Paxinos, G. pp. 129-152. Sydney: Academic press.
30. URBAN, L., THOMPSON, S.W. & DRAY, A. (1994). Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci., 17, 432-438.
31. WALKER, D., CARRINGTON, A., CANNAN, S.A., SAWICKI, D., SREDY, J., BOULTON, A.J. & MALIK, R.A. (1999). Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. J. Anat., 195, 419-427.
32. YAKSH, T.L. & CHAPLAN, S.R. (1997). Physiology and pharmacology of neuropathic pain. Anaesthesiol. Clin. North. Am., 15, 335-352.